MicroAlgo (VENAF) Common Equity (2020 - 2025)

MicroAlgo (VENAF) has 6 years of Common Equity data on file, last reported at $331.8 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity rose 128.72% year-over-year to $331.8 million; the trailing twelve-month figure through Dec 2025 stood at $331.8 million (up 128.72% YoY), and the FY2025 full-year result was $330.3 million, up 127.9% from the prior year.
• Common Equity for Q4 2025 stood at $331.8 million, up from $320.8 million in the prior quarter.
• Across five years, Common Equity topped out at $331.8 million in Q4 2025 and bottomed at -$3.3 million in Q3 2022.
• The 5-year median for Common Equity is $52.8 million (2021), against an average of $77.1 million.
• The widest annual swing landed in 2021, when Common Equity plunged 218430.9%; it then surged 4902.23% in 2022.
• A 5-year view of Common Equity shows it stood at $52.8 million in 2021, then jumped by 40.94% to $74.4 million in 2022, then slumped by 39.31% to $45.2 million in 2023, then soared by 221.15% to $145.1 million in 2024, then jumped by 128.72% to $331.8 million in 2025.
• The last three Common Equity figures came in at $331.8 million (Q4 2025), $320.8 million (Q2 2025), and $145.1 million (Q4 2024), per Business Quant data.

Peer Comparison